EGFR and non-small cell lung carcinoma: Between January 2012 and June 2018, Among the 229 consecutive patients with EGFR-mutated advanced NSCLC, three patients were excluded due to short EGFR-TKI treatment (< 1 month), and 69 patients were excluded due to synchronous BM.